Wall St. flat as banks, Amgen weigh; Adobe rallies

Go back to Wall St. flat as banks, Amgen weigh; Adobe rallies

Tiffany & Co. (TIF) PT Raised to $89 at Credit Suisse

March 17, 2017 1:07 PM EDT

Credit Suisse raised its price target on Tiffany & Co. (NYSE: TIF) to $89.00 (from $73.00) while maintaining a Neutral rating.

... More

Amgen (AMGN) FOURIER Results 'Good Enough' - Cowen

March 17, 2017 11:23 AM EDT

Cowen analyst Eric Schmidt weighed in on Amgen (NASDAQ: AMGN) after the highly anticipated FOURIER CV outcomes data details were presented at ACC. The firm maintained an Outperform rating and price target of $209 on AMGN. He said the results were "good enough" to gradually transform... More

While Amgen (AMGN) Primary Endpoint Was Below Expectations, Secondary Endpoint was Encouraging - Goldman Sachs

March 17, 2017 11:05 AM EDT

Goldman Sachs analyst Terence Flynn weighed in on Amgen (NASDAQ: AMGN) after full data from Repatha (PCSK9) Ph3 cardiovascular outcomes trial, FOURIER, was presented.

Flynn commented, "In our view the primary endpoint effect is likely below investor expectations (hence why AMGN... More

Adobe (ADBE) PT Raised to $145 at Canaccord Genuity

March 17, 2017 8:38 AM EDT

Canaccord Genuity raised its price target on Adobe (NASDAQ: ADBE) to $145.00 (from $125.00) while maintaining a Buy rating.

... More

Adobe (ADBE) PT Raised to $142 at Pacific Crest

March 17, 2017 8:36 AM EDT

Pacific Crest raised its price target on Adobe (NASDAQ: ADBE) to $142.00 (from $122.00) while maintaining a Overweight rating.

... More